Company
Zenas BioPharma (USA), LLC
Zenas BioPharma (USA), LLC has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Orelabrutinib | Phase 3 | Multiple Sclerosis (MS) Primary Progressive |
Latest
No recent events.
Follow Zenas BioPharma (USA), LLC on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.